Gravity Defyer Men’s G-Defy Mighty Walk Athletic Shoes
$98.96
19
Items sold in last 3 minutes
🔥Buy 3, Get 1 Free – Mix & Match Any Products!🔥
Estimated delivery dates: Jul 13, 2025 - Jul 14, 2025
13
People watching this product now!
Description
DETAILS
Don’t let the sleek design of the Mighty Walk fool you. This lightweight, breathable sneaker provides a secure fit with a soft interior lining and a low-profile design that packs the same VersoShock® technology** you’ve come to love.



FEATURES
- VersoShock® patented technology is clinically shown to relieve pain in the knees, by up to 85%*.
- Roomy Toe Box extra room for comfort and better blood circulation.
- Front Rolling Design designed to reduce foot stress by isolating 28 bones, 30 joints, and over 100 muscles from harm.
- Removable Insoles to accommodate custom orthotic support.
- Durable Breatable Mesh provides proper ventilation & flexibility.
- MEDICARE / HCPCS code = A5500 may be eligible for Medicare reimbursement.
- Free Corrective Fit Orthotics included– $50 Value. Orthotics provide full-body
alignment and perfect biomechanics.
Weight 10oz
Reviews (0)
Be the first to review “Gravity Defyer Men’s G-Defy Mighty Walk Athletic Shoes” Cancel reply
Related products

Select options
This product has multiple variants. The options may be chosen on the product page

Select options
This product has multiple variants. The options may be chosen on the product page

Select options
This product has multiple variants. The options may be chosen on the product page

Select options
This product has multiple variants. The options may be chosen on the product page

Select options
This product has multiple variants. The options may be chosen on the product page

Select options
This product has multiple variants. The options may be chosen on the product page

Select options
This product has multiple variants. The options may be chosen on the product page

Select options
This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.